Anales de la RANM

19 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 MIGRATION AND HEALTH INEQUITY Aagaard-Hansen J, et al. An RANM. 2025;142(01): 11 - 20 22. Alvar J, Beca-Martínez M, Argaw D, Saurabh J, Aagaard J. Social determinants of visceral leishmaniasis elimination in Eastern Africa. BMJ Glob Health 2023;8:e012638. doi:10.1136/ bmjgh-2023-012638. 23. Alvar J, Vélez ID, Bern C, et al. Leishmaniasis Worldwide and Global Estimates of Its Inci- dence. PLoS One. 2012;7(5): e35671. https:// dx.plos.org/10.1371/journal.pone.0035671. 24. Gadisa E, Tsegaw T, Abera A, Elnaiem D, den Boer M. Eco-epidemiology of visceral leishma- niasis in Ethiopia. Parasit Vectors. 2015;1–10. http://dx.doi.org/10.1186/s13071-015-0987-y. 25. Alvar J, Cañavate C, Molina R, Moreno J, Nie- to J. Canine Leishmaniasis. Adv Parasitol. 2004; 57:1–88. https://doi.org/10.1016/s0065- 308x(04)57001-x. 26. Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22(12):552– 557. https://linkinghub.elsevier.com/retrieve/ pii/S147149220600239X. 27. Alvar J, den Boer M, Dagne DA. Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflec- tions on an enhanced control strategy and a call for action. Lancet Glob Heal. 2021;9(12): e1763–9. http://dx.doi.org/10.1016/S2214- 109X(21)00392-2. 28. Berry I, Berrang-Ford L. Leishmaniasis, con- flict, and political terror: A spatio-temporal analysis. Soc Sci Med. 2016; 167:140–149. https://linkinghub.elsevier.com/retrieve/pii/ S0277953616302210. 29. Seaman J, Mercer AJ, Sondorp E. The epide- mic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol. 1996;25(4):862– 871. https://academic.oup.com/ije/article-loo- kup/doi/10.1093/ije/25.4.862. 30. Collin S, Davidson R, Ritmeijer K, et al. Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Pa- tients in Southern Sudan. Clin Infect Dis. 2004;38(5):612–619. https://academic.oup . com/cid/article-lookup/doi/10.1086/381203. 31. Argaw D, Mulugeta A, Herrero M, et al. Risk Factors for Visceral Leishmaniasis among Residents and Migrants in Kafta-Humera, Ethiopia. PLoS Negl Trop Dis. 2013;7(11): e2543. https://dx.plos.org/10.1371/journal. pntd.0002543. 32. Alvar J, Bashaye S, Argaw D, et al. Kala-azar outbreak in Libo Kemkem, Ethiopia: epide- miologic and parasitologic assessment. Am J Trop Med Hyg. 2007;77(2):275–282. http:// www.ncbi.nlm.nih.gov/pubmed/17690399. 33. Abubakar A, Ruiz-Postigo JA, Pita J, et al. Vis- ceral Leishmaniasis Outbreak in South Sudan 2009–2012: Epidemiological Assessment and Impact of a Multisectoral Response. PLoS Negl Trop Dis. 2014;8(3): e2720. https://dx.plos. org/10.1371/journal.pntd.0002720. 34. Harhay MO, Olliaro PL, Costa DL, Costa CHN. Urban parasitology: visceral leishmaniasis in Brazil. Trends Parasitol. 2011;27(9):403–409. https://linkinghub.elsevier.com/retrieve/pii/ S147149221100064X. 35. International Diabetes Federation (IDF). IDF Diabetes Atlas. 2023. https://diabetesatlas.org . Accessed 24 Jan 2023. 36. World Health Organizaton. Fact sheets on dia- betes. 2023. https://www.who.int/news-room/ fact-sheets/detail/diabetes. Accessed 10 Jun 2022. 37. Whiting D, Unwin N, Roglic G. Diabetes: equi- ty and social determinants. In: Equity, social determinants and public health programmes. In: E Blas and AS Kurup (Editors): Equity, social determinants and public health pro- grammes. Geneva: World Health Organiza- tion. 2010. pp.77-94. https://apps.who.int/iris/ handle/10665/44289. 38. World Health Organization. Global Tubercu- losis Report 2022. TB incidence. 2022. https:// www.who.int/teams/global-tuberculosis-pro- gramme/tb-reports/global-tuberculosis-re- port-2022/tb-disease-burden/2-1-tb-inciden- ce. Accessed 10 Jun 2022. 39. World Health Organization. Global tubercu- losis report 2022. 2022. https://www.who.int/ teams/global-tuberculosis-programme/tb-re- ports. Accessed 10 Jun 2022. 40. Centers for Disease Control and Prevention. Drug-Resistant TB. 2022. https://www.cdc . gov/tb/topic/drtb/default.htm. Accessed 10 Jun 2022. 41. Lönnroth, K, Jaramillo, E, Williams, B, Chris D and RM. Tuberculosis: the role of risk factors and social determinants. In: E Blas and AS Kurup (Editors): Equity, social de- terminants and public health programmes. Geneva: World Health Organization. 2010. pp.219–242. https://apps.who.int/iris/hand- le/10665/44289. 42. Baggaley RF, Zenner D, Bird P, et al. Preven- tion and treatment of infectious diseases in mi- grants in Europe in the era of universal health coverage. Lancet Public Heal. 2022;7(10): e876–84. http://dx.doi.org/10.1016/S2468- 2667(22)00174-8. 43. Musa BM, Adamu AL, Galadanci NA, Zuba- yr B, Odoh CN, Aliyu MH. Trends in pre- valence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One. 2017;12(9): e0185105. https://dx.plos.org/10.1371/journal. pone.0185105. 44. The Global Fund. Global Fund supported TB/ MDR-TB programs in Eastern Europe and Cen- tral Asia - focus on Uzbekistan, Kyrgyzstan, and Tajikistan. 2022. https://www.theglobalfund . org/en/oig/updates/2022-08-26-audit-of-mdr- tb-programs-in-eastern-europe-and-central- asia/. Accessed 10 Jun 2022. 45. Woldesemayat EM. Tuberculosis in Migrants is Among the Challenges of Tuberculosis Control in High-Income Countries. Risk Manag Health Policy. 2021; 14:2965–2970. https://www. dovepress.com/tuberculosis-in-migrants-is- among-the-challenges-of-tuberculosis-contr- peer-reviewed-fulltext-article-RMHP. 46. WHO. Implementing the end TB strategy: the essentials. 2022. https://apps.who.int/iris/ handle/10665/206499. Accessed 10 Jun 2022.